NCT00005637View on ClinicalTrials.gov

Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Primary Completion Date

June 30, 2003

Study Completion Date

December 31, 2009

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

carmustine

DRUG

temozolomide

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00005637 - Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma | Biotech Hunter | Biotech Hunter